23andMe Buys Telehealth Provider Lemonaid for $400M
Originally conceived for users to learn about genetic characteristics, 23andMe has been moving into therapeutics.
Use phrases "in quotes" or the tools below to better filter your results.
Enter the email associated with your account and we'll send you a link to reset your password.
